Physician profile
Sherry E Webber
NPI 1154985646
$1,481.80
in general payments reported to CMS, 2019-2025
20 companies · $48.14 in 2025
The $48.14 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $897 · 2022: $322 · 2023: $180 · 2024: $34.74 · 2025: $48.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $351.04 | 2021-2023 | Rybelsus, Ozempic |
| Esperion Therapeutics, INC. | $193.69 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $169.21 | 2021 | |
| Lilly USA, LLC | $136.18 | 2021-2023 | Mounjaro, Jardiance, Emgality |
| Abbvie INC. | $133.41 | 2021-2023 | |
| Eisai INC. | $68.14 | 2021 | |
| Ibsa Pharma INC. | $54.59 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.28 | 2021-2022 | |
| Exact Sciences Corporation | $48.14 | 2025 | The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $44.00 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $36.63 | 2022 | |
| Si-Bone, INC. | $34.74 | 2024 | |
| Arbor Pharmaceuticals, INC. | $25.34 | 2021 | |
| Hologic Sales and Service, LLC | $24.80 | 2022 | |
| Glaxosmithkline, LLC. | $24.44 | 2023 | Shingrix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $21.73 | 2021 | |
| Antares Pharma, INC. | $20.54 | 2023 | Nocdurna, Xyosted, Tlando |
| Biohaven Pharmaceuticals, INC. | $19.10 | 2021 | |
| Currax Pharmaceuticals LLC | $13.35 | 2022 | |
| Vistapharm, INC. | $11.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherry Webber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.